GlassScriptPhysician profile
Lisa Novak
NPI 1124329537
$2,735.08
in general payments reported to CMS, 2019-2025
12 companies · $956 in 2025
The $956 reported for 2025 was more than what 80% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $166 · 2022: $660 · 2023: $436 · 2024: $517 · 2025: $956.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,909.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,909.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $927.68 | 2021-2025 | Rexulti, Abilify Maintena |
| Otsuka America Pharmaceutical, INC. | $417.30 | 2022-2025 | Rexulti |
| Bausch Health US, LLC | $311.50 | 2022-2025 | Aplenzin, Wellbutrin |
| Abbvie INC. | $284.50 | 2024-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $235.53 | 2022-2023 | Trintellix |
| Alfasigma USA, INC. | $159.17 | 2021-2022 | |
| Axsome Therapeutics, INC. | $154.66 | 2023-2025 | Auvelity |
| Idorsia Pharmaceuticals US INC | $70.38 | 2022-2024 | Quviviq |
| Lilly USA, LLC | $61.79 | 2025 | Zepbound, Mounjaro |
| Alkermes, INC. | $50.20 | 2022-2023 | Lybalvi, Aristada |
| Collegium Pharmaceutical, INC. | $38.11 | 2025 | Jornay Pm |
| Neurocrine Biosciences, INC. | $24.26 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Novak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.